Fidelity® MSCI Health Care ETF (FHLC)
40.93
+0.01 +0.02%
NYSE Arca
May 25, 20:00
Delayed 2m
USD
FHLC Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All FHLC News
FHLC News
-
WireHeadlineTime (ET)
-
Yahoo04/17 17:02
-
Yahoo04/17 11:49
-
Yahoo04/03 14:59
-
Yahoo03/12 15:54
-
SA Breaking News10/30 14:55
-
SA Breaking News10/25 19:18
-
SA Breaking News10/17 14:47
-
SA Breaking News10/13 02:38
-
SA Breaking News09/29 17:23
-
SA Breaking News09/22 14:21
FHLC Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 2.18% | 2.12% | 4.82% | 84 |
| 3M | -1.01% | -0.94% | 1.34% | 64 |
| 6M | 4.12% | 4.17% | 8.35% | 69 |
| YTD | 2.68% | 2.72% | 6.40% | 65 |
| 1Y | 13.35% | 13.46% | 17.63% | 52 |
| 3Y | 5.61% | 5.65% | 3.77% | 28 |
| 5Y | -- | -- | 13.82% | -- |
| 10Y | -- | -- | 13.36% | -- |
FHLC Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.06% | 0.06% | 0.00% |
| Stock | 99.94% | 99.94% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
FHLC Region Exposure
| Americas | 99.89% |
| North America | 99.87% |
| Latin America | 0.02% |
| Greater Europe | 0.10% |
| United Kingdom | 0.10% |
| Europe Developed | 0.00% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
FHLC Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.04% |
| Healthcare | 98.43% |
| Industrials | 0.06% |
| Real Estate | 0.00% |
| Technology | 1.48% |
| Utilities | 0.00% |
FHLC Stock Market Capitalization
| Giant | 47.32% |
| Large | 33.43% |
| Medium | 12.89% |
| Small | 5.71% |
| Micro | 0.65% |
FHLC Stock Style Exposure
| Large Cap Value | 30.89% |
| Large Cap Blend | 20.48% |
| Large Cap Growth | 29.52% |
| Mid Cap Value | 1.16% |
| Mid Cap Blend | 2.68% |
| Mid Cap Growth | 9.07% |
| Small Cap Value | 0.52% |
| Small Cap Blend | 2.05% |
| Small Cap Growth | 3.64% |
View More Holdings
As of May 25, 2018
FHLC Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.64% | 121.47 | -0.64% |
| UNH | UnitedHealth Group Inc | 6.28% | 244.95 | +0.91% |
| PFE | Pfizer Inc | 5.63% | 35.68 | -0.59% |
| ABBV | AbbVie Inc | 4.27% | 101.08 | -2.00% |
| MRK | Merck & Co Inc | 4.26% | 59.09 | -0.07% |
| AMGN | Amgen Inc | 3.18% | 178.24 | +0.16% |
| MDT | Medtronic PLC | 3.09% | 86.30 | -0.79% |
| ABT | Abbott Laboratories | 2.87% | 62.37 | -0.22% |
| GILD | Gilead Sciences Inc | 2.33% | 67.38 | -0.22% |
| BMY | Bristol-Myers Squibb Company | 2.29% | 52.77 | +0.15% |
Advertisement
FHLC One Page Reports
- One Page Report Download
FHLC Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Fidelity Investments |
| Benchmark Index | |
|---|---|
MSCI USA IMI/Health Care GR USD |
100.0% |
FHLC Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 1.84 yrs |
| Diane Hsiung | 4.28 yrs |
| Greg Savage | 4.28 yrs |
| Jennifer Hsui | 4.28 yrs |
FHLC Net Fund Flows
| 1M | -12.14M |
| 3M | 17.12M |
| 6M | 207.36M |
| YTD | 185.45M |
| 1Y | 325.90M |
| 3Y | 447.29M |
| 5Y | -- |
| 10Y | -- |
FHLC Risk Info
| Beta (5Y) | 0.9331 |
| Max Drawdown (All) | 20.41% |
| Historical Sharpe (10Y) | -- |
| Historical Sortino (All) | 1.514 |
| 30-Day Rolling Volatility | 12.19% |
| Daily Value at Risk (VaR) 1% (All) | 2.60% |
| Monthly Value at Risk (VaR) 1% (All) | 9.19% |
FHLC Fundamentals
| Dividend Yield TTM (5-25-18) | 1.37% |
| SEC Yield | -- |
| Weighted Average PE Ratio | 26.13 |
| Weighted Average Price to Sales Ratio | 1.807 |
| Weighted Average Price to Book Ratio | 3.878 |
| Weighted Median ROE | 14.59% |
| Weighted Median ROA | 3.58% |
| Forecasted Dividend Yield | 1.54% |
| Forecasted PE Ratio | 15.91 |
| Forecasted Price to Sales Ratio | 1.671 |
| Forecasted Price to Book Ratio | 3.447 |
| Number of Holdings | 336 |
FHLC Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.04% |
| Forecasted Book Value Growth | 6.43% |
| Forecasted Cash Flow Growth | 7.23% |
| Forecasted Earnings Growth | 1.58% |
| Forecasted Revenue Growth | 8.60% |
FHLC Attributes
| Key Dates | |
|---|---|
| Inception Date | 10/21/2013 |
| Termination Date | |
| Last Annual Report Date | 7/31/2017 |
| Last Prospectus Date | 11/29/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
FHLC Excel Add-In Codes
- Name: =YCI("FHLC","name")
- Broad Asset Class: =YCI("FHLC", "broad_asset_class")
- Broad Category: =YCI("FHLC", "broad_category_group")
- Prospectus Objective: =YCI("FHLC", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
